National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
Pathak et al. (2016), PeerJ, DOI 10.7717/peerj.1738; 1-14
On the road to ending TB
Highlights from the 30 highest TB burden countries
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
UNAIDS 2016 / Meeting Report
Int J Vaccines Vaccin 2016, 2(1): 00018, January 29, 2016
This article describes a Community-Based Participatory Approach (CBPA) for children with intellectual disability in Endosulfan affected areas of Kasaragod district in Kerala state of India. The CBPA strategy evolved from Community Based Rehabilitation (CBR) and was led by Local Self-Government (LSG)... members. It involves a four-pronged approach encompassing family, community, service centres and LSG, with a focus on income generation activities and creation of employment opportunities. The CBPA model considers the cultural
uniqueness and limited resources in areas where the unscientific and extensive use of pesticides has led to high prevalence of multiple deformities including intellectual disabilities.
more
Malawi Integrated Guidelines and Standard Operating Procedures for Providing HIV Services. 3rd edition 2016
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
Strengthening Community responses to HIv Treatment and Prevention
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986